Andus, Baby Boy .

HRN: 28-73-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2026
03/30/2026
IV
33mg
Q24H
PSNB ( THICKLY MSAF)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: